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Macrophages reside in essentially all tissues of the
body and play key roles in innate and adaptive im-
mune responses. Distinct populations of tissue mac-
rophages also acquire context-specific functions
that are important for normal tissue homeostasis.
To investigate mechanisms responsible for tissue-
specific functions, we analyzed the transcriptomes
and enhancer landscapes of brain microglia and
resident macrophages of the peritoneal cavity. In
addition, we exploited natural genetic variation as
a genome-wide ‘‘mutagenesis’’ strategy to identify
DNA recognition motifs for transcription factors
that promote common or subset-specific binding of
the macrophage lineage-determining factor PU.1.
We find that distinct tissue environments drive diver-
gent programs of gene expression by differentially
activating a common enhancer repertoire and by
inducing the expression of divergent secondary
transcription factors that collaborate with PU.1 to
establish tissue-specific enhancers. These findings
provide insights into molecular mechanisms by
which tissue environment influences macrophage
phenotypes that are likely to be broadly applicable
to other cell types.INTRODUCTION
Macrophages are phagocytic cells of the innate immune system
that populate every organ, making key contributions to their
development, functions, and protection against infections and
injuries (Geissmann et al., 2010; Gordon et al., 2014; Wynn
et al., 2013). Accordingly, each population of tissue macro-
phages must adapt to its surrounding environment and engage
in tissue-specific functions to be effective auxiliary cells. In sup-port of this, recent mRNA profiling studies revealed significant
differences between distinct populations of resident tissue mac-
rophages (Gautier et al., 2012; Okabe and Medzhitov, 2014).
Thus, in spite of common elements shared across all subtypes
of tissue macrophages, including dependency on the transcrip-
tion factor PU.1 and signaling downstream of the CSF1 receptor
for ontology and survival (Schulz et al., 2012; Wynn et al., 2013),
each subset of tissue macrophage possesses its own unique
gene expression profile that presumably allows it to function in
synergy with the tissue in which it resides.
Accumulating evidence suggests that signaling factors
derived from tissue environments play key roles in promoting
the ontology and phenotype of the residing macrophage popula-
tions. For example, absence of TGF-b1 signaling in the mouse
brain impairs the development of the microglia population (Bu-
tovsky et al., 2014; Makwana et al., 2007). In the peritoneum,
omentum-derived retinoic acid (RA) promotes expression of
Gata6 in a subpopulation of local macrophages (Okabe and
Medzhitov, 2014). Interestingly, Gata6 expression is exclusive
to this particular tissue macrophage population, and decreasing
or eliminating its expression interferes with their functions and
survival (Gautier et al., 2012, 2014; Okabe and Medzhitov,
2014; Rosas et al., 2014).
Precisely how these and other signals act on macrophages at
the genomic level to promote specialized phenotypes and
unique transcriptional signatures remains unknown. However,
strong evidence suggests that enhancers, which are funda-
mental determinants of gene expression, may play a key role in
this context (Andersson et al., 2014; Levine, 2010; Shlyueva
et al., 2014). Enhancers, in comparison to promoters, exhibit sig-
nificant enrichment for combinations of DNA recognition motifs
that correspond to binding sites for lineage-determining tran-
scription factors (LDTFs), which are required for the develop-
ment of distinct cell types. Different patterns of LDTF expression
drive the selection of cell-specific repertoires of enhancers that
are considered to be central to the establishment of cell identity
and regulatory potential.
Studies of primary macrophages and B cells indicated that
PU.1 acts as an essential LDTF that contributes to the selectionCell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc. 1327
of a large fraction of the cell-specific enhancer-like elements in
each of these cell types (Barozzi et al., 2014; Ghisletti et al.,
2010; Heinz et al., 2010). Macrophage-specific enhancer selec-
tion by PU.1 required collaborative interactions with additional
macrophage-restricted transcription factors (TFs), including C/
EBP and AP-1 factors (Heinz et al., 2013). In contrast, B-cell-spe-
cific enhancer selection by PU.1 required collaborative interac-
tions with B-cell-restricted factors, including EBF and E2A (Heinz
et al., 2010).
Pre-existing enhancer landscapes occupied by PU.1 and/or
C/EBP factors were shown to be the major sites that bound
signal-dependent transcription factors (SDTFs), such as NFkB,
nuclear receptors, and STAT proteins (Ostuni et al., 2013; Heinz
et al., 2010). A similar hierarchical relationship for LDTFs and
SDTFs was found in regulatory T cells, embryonic stem cells,
and dendritic cells (Mullen et al., 2011; Samstein et al., 2012;
Garber et al., 2012). The collaborative and hierarchical relation-
ship of LDTFs and SDTFs at pre-existing enhancers was vali-
dated at the level of the DNA template by studies of effects of
natural genetic variation on enhancer selection and function
(Heinz et al., 2013). Mutations in PU.1 motifs causing loss of
PU.1 binding resulted in loss of the collaborative binding of C/
EBPa. Conversely, mutations in C/EBP motifs causing loss of
C/EBPa binding resulted in a loss of collaborative binding of
PU.1. Either type of mutation abolished signal-dependent bind-
ing of NFkB, whereas mutations in NFkB motifs that abolish
NFkB binding rarely affected the binding of PU.1 or C/EBPa.
However, in contrast to the picture at pre-existing enhancers,
NFkB was also shown to be capable of selecting ‘‘latent’’ or
‘‘de novo’’ enhancers by collaborating with PU.1 to bind to
genomic locations lacking prior features associated with active
enhancers (Kaikkonen et al., 2013; Ostuni et al., 2013). These ob-
servations provide an example of an environmentally driven
modification of the enhancer repertoire by a broadly expressed
SDTF that is nonetheless cell type specific due to the obligatory
participation of PU.1.
Given that each tissue environment is distinguished by a
unique combination of signaling factors, it is likely that gene
expression in each corresponding macrophage population is
under the control of distinct combinations of SDTFs that can
modulate the activity of a pre-existing enhancer repertoire to
achieve context-dependent gene expression. In addition, it is
also possible that environmental signals control the expression
and activities of TFs that result in selection of tissue-specific en-
hancers, analogous to the establishment of ‘‘latent’’ or ‘‘de novo’’
enhancers. Here, we sought to determine the extent to which
environment shapes distinct macrophage enhancer repertoires
and the underlying mechanisms.
RESULTS
Environment-Specific Gene Expression
To investigate mechanisms responsible for tissue-specific
macrophage phenotypes, we isolated microglia (MG; brain
macrophages) and two distinct populations of resident perito-
neal macrophages (RPMs) that are discriminated by cell-sur-
face expression levels of MHCII—large peritoneal macrophages
(LPMs, low MHCII) and small peritoneal macrophages (SPMs,1328 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.high MHCII)—by flow cytometry (Figures S1A and S1B available
online) (Ghosn et al., 2010; Okabe and Medzhitov, 2014) (Fig-
ure 1A). These three populations of macrophages allow com-
parisons of gene expression and epigenetic landscapes in
distinct macrophage populations residing in the same envi-
ronment (i.e., LPMs versus SPMs), as well as different envi-
ronments (i.e., LPM versus MG). In addition, we included
thioglycollate-elicited peritoneal macrophages (TGEMs) and
bone-marrow-derived macrophages (BMDMs) for comparison,
as these macrophages, although maintained in culture condi-
tions, are widely used models of macrophage biology that are
derived from different sources (Figure 1A).
Gene expression profiles determined by RNA sequencing
(RNA-seq) from independent biological replicates revealed sub-
stantial differences in the patterns of gene expression across the
different macrophage populations examined (Figures 1B, 1C,
and S1C and Table S1), in agreement with previous studies
(Gautier et al., 2012; Okabe and Medzhitov, 2014). In particular,
7,000 genes are differently expressed in MG compared to
LPMs (p value < 0.01), with >500 genes being >16-fold more
highly expressed in MG and >600 genes being >16-fold more
highly expressed in LPMs. On the other hand, LPMs and SPMs
share strong similarities (Figure 1C), with SPMs expressing
only 108 genes > 16-fold higher than LPMs, and LPMs express-
ing only 5 genes > 16-fold higher than SPMs. These results
corroborate many previous findings, including the highest level
of expression of Cx3cr1 in MG and the selective expression of
Gata6 in RPMs (Figure 1D) (Cardona et al., 2006; Gautier et al.,
2012; Jung et al., 2000; Okabe and Medzhitov, 2014). Interest-
ingly, Ciita, a transcription factor that regulates MHCII expres-
sion (Steimle et al., 1993), is preferably expressed in the SPM
population (Figure 1D). Finally, gene clustering analyses
confirmed that, whereas LPMs and SPMs show highly similar
gene expression, MG differ substantially from the other macro-
phage subsets (Figure 1E). TGEMs and BMDMs are also more
similar to one another than either one is to any of the three in vivo
subsets, potentially reflecting the similarity of the cell culture
environment. Overall, these findings suggest a strong role of
environment in determining macrophage gene expression.
Common and Distinct Macrophage Enhancer
Repertoires
The dissimilarities in gene expression between different macro-
phage subsets revealed by RNA-seq analysis imply important
differences in how these cells organize and/or use their enhancer
repertoires. To examine this, we analyzed dimethylation status
of lysine 4 of histone 3 (H3K4me2) and acetylation status of
lysine 27 of histone H3 (H3K27ac) by chromatin immunoprecip-
itation sequencing (ChIP-seq) in these cells (Figure S2 and Ta-
bles S2, S3, and S4). H3K4me2marks promoters and enhancers
(He et al., 2010; Kaikkonen et al., 2013), whereas H3K27ac
correlates positively with transcriptional activity at these ele-
ments (Creyghton et al., 2010). Deposition of H3K4me2 results
from the binding of LDTFs and other TFs but is not necessarily
associated with enhancer activity. We therefore use a heuristic
of defining H3K4me2-positive/H3K27ac-negative regions as
‘‘primed’’ and regions positive for both marks as ‘‘active.’’
Genomic annotation enabled segregation of these regions into
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Figure 1. Variation in Gene Expression in Different Macrophage Subsets
(A) Macrophage subsets used for analysis and corresponding environmental factors (see Figures S1A and S1B for sorting protocols).
(B and C) Scatterplots illustrating relative gene expression of polyA-selected RNA transcripts in MG compared to LPMs (B) and SPMs compared to LPMs (C).
Values are log2 of tag counts normalized to 107 uniquely mapped tags. See Figure S1C for a representative replicate.
(D) Relative gene expression means for the indicated genes are shown from replicate RNA-seq experiments (error bars represent SD).
(E) Heat map of transcripts exhibiting an expression value of at least 64 normalized tags in at least one subset and differing in expression by at least 16-fold in at
least one of the indicated subsets.
See also Table S1.promoters or enhancers by proximity to gene transcriptional
start sites (TSS). Notably, the pattern of H3K4me2 deposition
in MG substantially differs from that of LPMs (Figure 2A),
indicating selection of distinct regulatory landscapes. Of 7,937promoters marked by H3K4me2 in one or both subsets, 275
exhibit >4-fold differences (3%), far fewer than the 1,700
mRNAs exhibiting >16-fold differences in expression. Of
36,607 regions > 500 bp from TSS marked by H3K4me2 in oneCell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc. 1329
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Figure 2. Variation in Enhancer Landscapes in Different Macrophage Subsets
(A) Scatterplots of normalized H3K4me2 tag counts at genomic regions marked by significant H3K4me2 tags in LPMs and/or MG (left) or LPMs and/or SPMs
(right). Points colored in blue are within 500 bp of a TSS. See Figure S2 for representative replicates.
(B) Heatmaps of normalized H3K4me2, H3K27ac, and nearest expressed gene RNA-seq tag counts at genomic locations showing >4-fold pairwise differences in
H3K4me2 tag counts between at least two of the five macrophage subtypes. Row order is the same for all three data types.
(C) Scatterplots of normalized H3K27ac tag counts at genomic regions marked by significant H3K27ac tags in LPMs and/or MG (left) or LPMs and/or SPMs
(right). Points are colored red if genomic locations are also marked by H3K4me2 (>16 tags) in both subsets, green if marked by H3K4me2 selectively in MG
(left) or SPMs (right), yellow if marked by H3K4me2 selectively in LPMs, or blue if not associated with H3K4me2 in either subset.
(legend continued on next page)
1330 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.
or both subsets, 9,083 exhibit >4-fold differences (24%). The
vast majority of differential H3K4me2-marked regions are
thus distant from promoters and correspond to potential en-
hancers. In contrast to the comparison of LPMs and MG, both
the enhancer and promoter repertoires of the two subsets of
RPMs share a much higher degree of similarity (Figure 2A).
Furthermore, clustering analyses of the H3K4me2 deposition
pattern revealed that MG were more divergent from the other
subsets than any two other macrophage subsets are from
one another, which is consistent with gene expression data
(Figure 2B).
H3K27ac was present at a large fraction of H3K4me2-marked
regions and generally but imperfectly correlated with nearest
gene expression (Figure 2B). Overlap of the H3K27ac data
with H3K4me2-defined enhancers allowed the identification of
common but quantitatively differently activated enhancers, as
well as activation of enhancers unique to one subset. Figure 2C
illustrates such comparisons for LPMs versus MG and LPMs
versus TGEMs. Genomic regions marked by H3K4me2 in both
subsets are color coded in red and represent activation of an
enhancer landscape that is primed in both subsets. In contrast,
regions exclusively marked by H3K4me2 in LPMs, shown in yel-
low, represent LPM-specific enhancers. Conversely, regions
exclusively marked by H3K4me2 in MG or TGEMs, indicated in
green, represent MG or TGEM-specific enhancers, respectively.
Comparing LPMs versus MG, 60% of the active enhancers
resided at common regions of H3K4me2, 30% at LPM-specific
regions, and 10% at MG-specific regions. Specific examples
are indicated in Figure 2D. As expected, the Spi1 enhancer,
controlling expression of PU.1, is marked by H3K4me2 and
H3K27ac in all macrophage populations. Interestingly, the RA-
inducible Rarb gene is also marked by H3K4me2 in all macro-
phage populations, but high H3K27ac is only observed in
LPMs and SPMs, suggesting a role of local RA in enhancer acti-
vation. Finally, the Sall3 gene, which is exclusively and highly ex-
pressed in MG, is near a genomic region that is exclusively
marked by H3K4me2 and H3K27ac in MG. In sum, these ana-
lyses provide strong evidence that both differential activation
of a common enhancer landscape and the selection of sub-
type-specific enhancers contribute to the specific transcriptional
signature of each subset of macrophages.
Tissue-Specific Super-Enhancers Emerge from
Common Enhancer Landscapes
Genome-wide analysis of features of active enhancers, including
the presence of Mediator and deposition of H3K27ac, indicates
marked variation in their local distribution patterns. In all cell
types evaluated thus far,400–800 regions, representing a small
fraction of the genome, exhibit a disproportionately high density
of active regulative marks and transcription factor binding (Hnisz
et al., 2013; Love´n et al., 2013; Whyte et al., 2013). These re-
gions, recently termed super-enhancers (SEs), are selected in
a cell-specific manner and frequently occur near or encompass(D) UCSC browser images of selected genomic regions with corresponding RNA-
vertical highlights designate regions of interest for subset-common (Spi1) or sub
dimension.
See also Tables S2, S3, and S4.genes that play essential roles in defining the identity and func-
tion of the corresponding cell type (Hnisz et al., 2013). Although
LDTFs are enriched in and likely determine cell-specific SE se-
lection, evidence also suggests that the extracellular environ-
ment can influence formation of SEs in endothelial cells (Brown
et al., 2014). To investigate this relationship in tissue macro-
phages, we defined SEs in each macrophage subset based on
H3K27ac ChIP-seq. In agreement with previous studies, we
observed common and subset-specific SEs, with 600 to 750
SEs being identified among the five cell types examined. Clus-
tering of these SEs results in the same relationships between
subsets as observed using RNA-seq, H3K4me2, or H3K27ac
data (Figure 3A). This analysis also revealed a high concordance
between the distribution of SEs genomewide and the expression
level of the nearest genes (Figure 3A). This strong relationship is
further illustrated for SEs and nearest gene expression inMGand
LPMs, in which the correlation coefficient was 0.62 (Figure 3B),
much higher than that observed for the individual enhancer ele-
ments not associated with SE regions in these subsets. This may
be due to a more accurate assignment of SEs to their target
genes than conventional enhancers.
Approximately 40% to 50% of the SEs in a particular macro-
phage subset are unique to that subset, illustrated by the Venn
diagram of LPM, MG, and TGEM in Figure 3C. In concert with
previous findings (Hnisz et al., 2013;Whyte et al., 2013), common
SEs are associated with numerous genes important to macro-
phage ontology and functions, including Spi1, Cebpa, members
of the Irf family,Csf1r, Fcgr2b,Ctsb, etc. (Figure 3D). This pattern
is exemplified by the region upstream of Spi1, which is scored as
a SE in all five subsets (Figure 2D). In contrast, many SEs are
macrophage subset specific and reside near or surround genes
that are highly differentially expressed (Figure 3E). Although
some SEs exhibit highly specific H3K4me2 and H3K27ac mark-
ings, such as the LPM-specific SE upstreamofGata6 (Figure 3E),
the majority of SEs are located at regions that are marked by
H3K4me2 in multiple macrophage subsets but only attain SE
status in one or a few subsets. For example, LPM-specific SEs
reside in the vicinity of Rarb (Figure 2D) and Alox15 (Figure 3E)
genes, which are selectively expressed in LPMs but that also
exhibit H3K4me2 in other macrophage subsets. Similar relation-
ships are observed for the MG-specific SEs surrounding Gpr56
and Cx3cr1 and the TGEM-specific SEs surrounding Fabp5
and Gpnmb (Figure 3E). These findings suggest that environ-
mental signals play roles in the transition of collections of primed
enhancers to genomic regions exhibiting features of SEs.
PU.1 Colocalizes with Distinct TF Motifs at Subset-
Specific Enhancers
The observation that PU.1 localization to macrophage- or B-cell-
specific enhancers is dependent on collaborative interactions
with alternate LDTFs (Heinz et al., 2010) led us to consider the
possibility that an assessment of PU.1 binding in different
macrophage subsets might yield insights into the TFs thatseq data plotted as bar graphs. Bars labeled SE indicate super-enhancers, and
set-specific (Rarb and Sall3) loci. All data are normalized to input and library
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Figure 3. Variation in Super-Enhancer
Landscapes in Different Macrophage Sub-
sets
(A) Heatmaps of H3K27ac tag densities at super-
enhancers and RNA-seq tag densities at nearest
genes. Rows are ordered the same for both plots.
(B) Scatterplot of the relationship between ratio of
MG to LPMs H3K27ac tag density at super-en-
hancers (x axis) and the ratio of nearest gene
expression (y axis).
(C) Venn diagram indicating overlap and specificity
of super-enhancers in MG, LPMs, and TGEMs.
(D) Examples of genes associated with common
super-enhancers.
(E) UCSC genome browser images of selected
subset-specific super-enhancers and associated
genes with subset-specific regions of interest
highlighted.drive the selection of subset-specific enhancers. We therefore
extended existing genome-wide binding profiles for PU.1 to
include MG, LPMs, and SPMs. These studies indicated that
PU.1 bound to both common and subset-specific genomic loca-
tions, exemplified for LPMs and MG in Figure 4A (all compari-
sons in Tables S2 and S3). The great majority of subset-specific
binding sites were observed at distal regions (>500 bp from an
mRNA TSS, Figure 4A), which is consistent with the patterns of
H3K4me2 (Figure 2A). Examples of LPM-specific and MG-spe-
cific binding sites for PU.1 in enhancer-like regions vicinal to
Msr1 (expressed exclusively in LPMs) and Nav2 (expressed
exclusively in MG) genes are illustrated in Figure 4B.
De novo motif enrichment analysis of 200 bp sequences
encompassing PU.1 peaks identified the identical PU.1 recogni-
tion motif in both LPMs and MG as the most enriched sequence.
However, completely different motifs were coenriched within the
two subsets (Figures 4C and 4D). Using GC content-matched
genomic sequence as background, enriched sequences specific
to LPMs corresponded to motifs known to bind C/EBP, AP-1,1332 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.IRF, KLF, and GATA transcription factor
family members (Figure 4C). Conversely,
MG-specific PU1-binding sequences
were coenriched for a PU.1-IRF compos-
ite sequence and motifs corresponding
to CTCFL, HIC2, MEF2, and SMAD TFs
(Figure 4D). In addition, by using alterna-
tive subset-specific PU.1-binding sites
as background, motifs recognized by ret-
inoic acid receptors (e.g., NR2F2) were
identified to be coenriched with PU.1-
binding sites in LPMs (Figure 4C).
Previous studies indicated that motifs
for collaborative binding partners of
PU.1 typically reside within 100 bp of
the PU.1 motif itself (Barozzi et al., 2014;
Heinz et al., 2010). We therefore analyzed
the genomic distance distribution of en-
riched motifs (from Figures 4C and 4D)
within a 400 bp window relative to thebound PU.1 motif of LPM- and MG-specific PU.1 peak sets
(Figure 4E). This analysis indicated that C/EBP, AP1, and
GATA motifs frequently occurred near PU.1-bound motifs in
LPMs, but not in MG, indicating that genomic loci containing
PU.1 and closely spaced C/EBP, AP-1, or GATA motifs were
more likely to become LPM-specific enhancers. The GATA motif
was selectively enriched in LPMs relative to MG, suggesting a
fundamental difference for the LPM resident population
compared to elicited macrophages (Figure 4E). In contrast, the
SMAD motif showed MG specificity (Figure 4E), which is consis-
tent with TGFb signaling in the brain. These findings provide ev-
idence that selection of subset-specific enhancers is in part
driven by collaborative interactions between PU.1 and alterna-
tive sets of TFs in each subset.
Use of Natural Genetic Variation to Validate and
Discover Collaborative TFs
Although motif enrichment suggests the identities of TFs that
contribute to the function of subset-specific enhancers, this
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Figure 4. PU.1 Binds to Subset-Specific
Enhancers
(A) Scatterplot of normalized tag counts for PU.1
peaks in MG versus LPMs. Points colored blue are
within 500 bp of the TSS.
(B) UCSC genome browser images of PU.1 bind-
ing in the vicinity of the Msr1 and Nav2 genes in
MG and LPMs cells and association with H3K27ac
highlighting specific regions.
(C) Motifs enriched in the vicinity of PU.1-binding
sites that are specific for LPMs versus MG using a
random GC-corrected genomic background (top)
or a background corresponding to MG-specific
PU.1 peaks (bottom).
(D) Motifs enriched in the vicinity of PU.1-binding
sites that are specific for MG using a random GC-
corrected genomic background.
(E) Distribution plots of motif frequencies (y axis)
for the indicated motifs within 400bp centered on
the PU.1 motif at genomic loci bound specifically
by PU.1 in LPMs (blue) or MG (red).approach does not establish whether or not they are required
for collaborative binding. Loss-of-function strategies are chal-
lenging for this purpose because many of the identified motifs
are recognized by multiple members of corresponding TF fam-
ilies. An alternative means to test for collaborative binding is to
mutate motifs recognized by the TF family of interest and deter-
mine whether this results in loss of binding of a nearby factor. We
considered the possibility that this could be accomplished for
informative motifs on a genome-wide scale by leveraging the
vast degree of natural genetic variation provided by inbred labo-
ratory and wild strains of mice.
To explore the potential of this approach to validate and
discover TFs required for collaborative binding and function
of PU.1, we determined the genome-wide patterns of PU.1,
H3K4me2, and H3K27ac in LPMs and MG isolated from
NOD/ShiLtJ (NOD) and SPRET/EiJ (SPRET) mice (Table S5).Cell 159, 1327–1340, DCompared to C57BL/6J (C57) mice,
NOD mice have about 5 million SNPs
and indels, whereas SPRET mice have
about 40 million (Keane et al., 2011).
This variation is associated with corre-
sponding levels of strain-specific binding
of PU.1, illustrated for LPMs derived
from C57 and SPRET mice (Figure 5A).
Similar observations are made with
respect to MG (Table S6). Approximately
8-fold fewer strain-specific PU.1-binding
sites were identified in LPMs and MG
derived from NOD mice compared to
C57, which is consistent with the lower
number of variants between these two
strains. Strain-specific binding of PU.1
was associated with corresponding
strain-specific H3K4me2 and H3K27ac
marks (Figure 5B), suggesting that many
strain-specific PU.1-binding sites localize
to functional enhancers.
To search for motifs mediating DNA binding by collaborative
TFs, we analyzed strain-specific binding of PU.1 that was not
associated with mutations in PU.1 recognition motifs. This was
accomplished by scanning a 200 bp window surrounding
PU.1-binding sites lacking PU.1motif mutations for the presence
of the DNA recognition motifs of the 100 most highly expressed
TFs in LPMs and MG in C57 or the alternate (NOD or SPRET)
genomic sequence. Mutated loci were then queried for a corre-
sponding decrease in PU.1 binding relative to the unmutated
strain. The significant result for ISRE motif mutations affecting
PU.1 binding in LPMs is exemplified in Figure 5C. The ISRE
was found to be mutated in the vicinity of PU.1-binding sites
93 times in LPMs isolated from C57 mice (indicated by red
hash lines in Figure 5C) and 106 times in LPMs isolated from
SPRET mice (indicated by blue hash lines in Figure 5C). PU.1
binding strength is rank ordered from most C57 specific at leftecember 4, 2014 ª2014 Elsevier Inc. 1333
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Figure 5. Motif Mutations in Potential
PU.1 Collaborating Transcription Factors
Confirm Cooperative Binding for Sub-
set-Common and Subset-Specific Factor
Combinations
(A) PU.1 binding between SPRET and C57 is
shown for 200 bp regions where green signifies
differential binding (>4-fold, p < 1 3 104, n =
13,199), blue similar binding (<4-fold, p < 1 3
104, n = 11,022) and orange in between (n =
12,367).
(B) Heatmap of 2 kb differentially bound PU.1
genomic regions (rows) centered on PU.1 binding
for ChIP-seq tags of PU.1, H3K4me2, and
H3K27ac between C57 and SPRET (columns).
(C) An example of motif mutation analysis is shown
for the ISREmotif. 200 bp genomic sequence at all
PU.1 bound loci (in A) were queried for genetic
variants that mutated the ISRE motif matrix in
either C57 or SPRET. Mutations were colored
according to the genome mutated: red, C57; blue,
SPRET. ISRE mutations were plotted according to
the PU.1-binding strain ratio (y axis) as measured
in LPMs at that locus and rank-ordered on the x
axis. Boxplots of corresponding color indicate the
effect of ISRE motif mutations on PU.1 binding
where whiskers extend to data extremes and p
value are from two-sided t test.
(D) Results from analyses described in (C) are
vertically compressed and shown in rows for PU.1,
C/EBP, Unknown, AP-1, and ISRE motif mutation
events.
(E) Heatmap showing p values resulting from
analysis described in (C) and (D) for motif muta-
tions best matching transcription factors indicated
on x axis. Each motif was tested for affecting PU.1
binding between C57 and NOD and between C57
and SPRET both in MG and LPMs (y axis).
See also Figure S3 and Tables S5 and S6.to most SPRET specific at right. Many mutations are not associ-
ated with strain-specific binding, which is consistent with prior
studies indicating that the specific position of the variant (i.e.,
core versus periphery of motif), the distance of the motif from
the peak center, and presence of additional redundant motifs
affect the impact of individual mutations (Heinz et al., 2013).
Overall, however, C57 mutations in the ISRE were associated
with SPRET-specific binding of PU.1, whereas SPRETmutations
in the ISRE associated with C57-specific binding of PU.1 (p = 83
1010). This strong genetic association implicates factors bind-
ing to the ISRE as collaborative partners of PU.1 in LPMs.
This analysis was repeated for each motif of interest in each
macrophage subset (LPMs and MG) for the comparisons of
C57 versus NOD and C57 versus SPRET. Vertical compression
of the plot shown in Figure 5C allows stacking of plots for multi-
ple motifs, indicated in Figure 5D. Overall, 37 motifs were found
to reach statistical significance in at least one macrophage sub-
set and strain (Figures 5E and S3). Many more motifs were found
to be significant in comparisons of macrophages derived from
C57 and SPRET mice than C57 and NOD mice, which is consis-
tent with the much larger number of informative mutations. The
most highly significant motifs corresponded to sequences
recognized by ETS factors that are similar to motifs recognized1334 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.by PU.1 itself. Most of thesemotifs are closely situated to regions
of PU.1 binding for which the PU.1 motif itself was considered to
be intact. It is therefore unclear at present the extent to which
thesemutations directly affect PU.1 binding or represent binding
sites for collaborative ETS factors.
Twelve non-ETS motifs were identified as being significantly
associated with PU.1 binding in both LPMs and MG, including
a C/EBPa motif, which is an established collaborative binding
partner of PU.1 (Figure 5E). In contrast, 14 motifs exhibited pref-
erential associations with strain-specific PU.1 binding in LPMs
(Figure 5E). This list includes recognition motifs for KLF4,
GATA factors, and AP-1 factors, independently identifyingmotifs
discovered through de novo motif analysis. Finally, motifs for
four factors were preferentially associated with PU.1 binding in
MG, including a recognition motif for SMAD3.
Tissue Environment Regulates Collaborative and
Signal-Dependent TF Expression
To investigate the importance of tissue environment in mainte-
nance of specific macrophage phenotypes, we placed LPMs
and MG into culture under the influence of IL-34 or M-CSF for
7 days. Whereas M-CSF is important to peritoneal macrophages
(Witmer-Pack et al., 1993), IL-34 is critical for proper MG
A B D
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F
G
Figure 6. Environmental Influence on Gene
Expression in LPMs and Microglia
(A and B) Scatterplots illustrating relative gene
expression of RNA transcripts in freshly isolated
LPMs compared to LPMs maintained in culture for
7 days (A) and freshly isolated MG compared to
MG in culture for 7 days (B). Genes specific to
LPMs are colored blue in (A) and specific toMGare
red in (B).
(C) Normalized gene expression values for mem-
bers of the RAR and TGFb receptor family mem-
bers.
(D) Heatmap showing the fold-change of RNAs for
the indicated transcription factors upon removal
from the peritoneal cavity and culture with IL-34 or
M-CSF.
(E and F) Effects of chronic stimulation with RA in
M-CSF and/or IL34 (E) on LPM-specific or com-
mon mRNAs or TGFb in M-CSF or IL34 (F) on MG-
specific or common mRNAs.
(G) qPCR validation of maintained expression by
RA of key transcription factors in cultured LPMs
(error bars indicate SD).
See also Figure S4.ontology and/or survival in vivo (Greter et al., 2012; Wang et al.,
2012). This environmental transition resulted in vast changes
in gene expression (Table S7). Comparison of the gene expres-
sion program of LPMs freshly purified from the peritoneal cavity
with LPMs maintained in M-CSF for 7 days is illustrated in
Figure 6A. Data points colored in blue represent genes that
are expressed more than 16-fold higher in LPMs than MG, indi-
cating that the LPM-specific program of gene expression is
preferentially lost in culture. Comparison of the gene expression
program of MG freshly isolated from the brain or maintained in
culture in the presence of IL-34 for 7 days is illustrated in Fig-
ure 6B. Data points colored in red represent genes that are ex-
pressed more than 16-fold higher in MG than LPMs, indicating
that the MG-specific program of gene expression is preferen-
tially lost in culture. In both LPMs andMG,many genes exhibiting
low levels of expression in vivo are markedly upregulated in
culture.
In view of recent findings indicating important roles of TGFb
signaling in MG and RA signaling in peritoneal macrophages, we
examined the expression of the main receptors for these factorsCell 159, 1327–1340, Din each macrophage subset. The mRNAs
encoding all three RA receptors (Rara,
Rarb, and Rarg) are highly and selectively
expressed in LPMs and SPMs, whereas
mRNAs encoding the TGFb receptors
Tgfbr1 and Tgfbr2 are preferentially ex-
pressed in MG (Figure 6C). Interestingly,
expression of all three retinoic acid recep-
tors is markedly reduced when LPMs are
placed into culture in the presence of M-
CSF or IL-34, whereas the expression of
Tgfbr1 is markedly increased under these
conditions (Figure 6D). Thus, environmentcontrols the expression of genes responsible for responses to
environment-specific signals.
To investigate the extent to which RA and TGFb influence sub-
set-specific patterns of gene expression, we treated LPMs with
RA or TGFb for 7 days and performed RNA-seq analysis. RA
treatment induced expression of nearly half of the LPM-specific
genes bymore than 2-fold, while inducing about 8%of genes ex-
pressed at similar levels in LPMs and MG (Figure 6E).
Conversely, nearly 50% of the genes induced more than 2-fold
by TGFb in LPMs in culture are preferentially expressed by MG
in vivo, whereas only 4% of the genes expressed at similar levels
in LPMs and MG were induced by TGFb in LPMs (Figure 6F).
Thus, RA and TGFb disproportionately regulate genes that
specify LPM and MG-specific phenotypes, respectively.
We next evaluated the expression of TFs that recognize motifs
identified as putative binding sites for collaborative partners of
PU.1 in LPMs through analysis of strain-specific PU.1 binding.
Remarkably, expression of the majority of TFs best matched to
motifs identified by strains analysis was environment dependent
(Figure 6D). A similar pattern was observed when considering allecember 4, 2014 ª2014 Elsevier Inc. 1335
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Figure 7. Environmental Influence on En-
hancer Landscapes in LPMs and Microglia
(A) Effects of culture environment and RA chronic
stimulation on the enhancer landscape of LPMs.
(B) UCSC browser images displaying effects of
culture environment and RA chronic stimulation on
H3K4me2, H3K27ac, and PU.1 binding at the
Bhlhe40 locus in LPMs.
(C) Effects of culture environment and chronic
stimulation with TGFb on the enhancer landscape
of LPMs.
(D) UCSC browser images displaying effects of
culture environment and chronic stimulation with
TGF-b1 on H3K4me2, H3K27ac, and PU.1 binding
at the Ets1 locus in LPMs.
(E) Hierarchical model for mechanisms by which
the peritoneal environment induces the enhancer
landscape and gene expression signature of
LPMs. See Discussion for details.
See also Table S7.members of each TF family capable of recognizing these motifs
(Figure S4A). RNA-seq analysis further suggested that several
of these factors were inducible by RA. This response was
confirmed under M-CSF treatment conditions for Gata6 and
Rarb, consistent with previous studies (Okabe and Medzhitov,
2014), as well as for Bhlhe40 and Nfe2 (Figures 6G and S4B).
However, expression ofRara,Rarg, andmost of the other factors
illustrated in Figure 6C was not RA inducible. Thus, the environ-
ment modulates in LPMs the expression of collaborative and
SDTFs through both RA-dependent and RA-independent
mechanisms.
Hierarchical Effects of Environment on Macrophage
Enhancer Landscapes
To gain insights into mechanisms underlying effects of environ-
ment on macrophage gene expression, we performed ChIP-
seq analysis for H3K4me2, H3K27ac, and PU.1 in LPMs main-
tained in M-CSF and the presence or absence of RA or TGFb
for 7 days. Transition of LPMs from the peritoneal cavity to a
tissue culture environment containing M-CSF led to a >2-fold
reduction in H3K4me2 and/or H3K27ac at approximately half of1336 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.the enhancer-like regions (Figure 7A).
One-third of these lost enhancer elements
were maintained by RA treatment (Fig-
ure 7A).Of the 302 LPM-specificSEs iden-
tified in Figure 3, 223 (74%) no longer met
SE criteria, indicating a disproportionate
sensitivity to loss of environmental signals.
This pattern is exemplified by the SE asso-
ciated with Bhlhe40, which, in addition to
substantial reduction in the histone signa-
ture of enhancers, also exhibits reduced
PU.1 binding (Figure 7B). Notably,
H3K4me2, H3K27ac, and PU.1 binding
are largely maintained by RA treatment.
Maintenance of LPMs in M-CSF plus
TGFb resulted in marked changes in the
LPM enhancer landscape in comparison to culture in M-CSF
alone, which is consistent with the preferential effects of TGFb
on aMG-specific program of gene expression (Figure 7C). Treat-
ment with TGFb increased the enhancer signature by more than
2-fold at 25% of pre-existing enhancers. Conversely, TGFb
reduced enhancer signatures at 25% enhancer-like elements
that were stable upon transfer to culture in M-CSF. Induced en-
hancers are exemplified by a genomic region in the vicinity of the
Ets1 gene (Figure 7D) that is preferentially expressed in MG and
is highly induced by TGFb. Culture of LPMs in M-CSF results in
appearance of PU.1 binding and H3K4me2 modification, with
TGFb treatment leading to substantial increases in H3K27ac
and a marked increase in gene expression.
DISCUSSION
Mechanisms Underlying Tissue-Specific Enhancer
Selection and Activation
The present studies provide evidence for a hierarchical model in
which the distinct environments of the brain and peritoneal cavity
differentially activate a common set of primed enhancers and
their target genes that, in turn, promote the selection and activa-
tion of subset-specific enhancer repertoires. The combinatorial
activation of both common and subset-specific enhancers
enables context-dependent regulation of genes required for
specialized functions of MG and RPMs. Aspects of this model
as they pertain to the RA-dependent program of gene expres-
sion specific to peritoneal macrophages are illustrated in Fig-
ure 7E. Common to all macrophage subsets, stimulation of
signaling pathways downstream of the M-CSF receptor by M-
CSF and/or IL-34, which are present in the environment in a
largely tissue-non-specific manner, ensures survival and pro-
motes PU.1 expression (Sarrazin et al., 2009). PU.1 is a critical
LDTFs required for all macrophage subsets that functions to
select common and cell-specific enhancers through collabora-
tive interactions with other TFs. These regions of PU.1 binding
in turn serve as subset-specific sites of action for various types
of SDTFs.
Within the peritoneal cavity, environment-specific signals
control the expression and activities of TFs that act upon primed
enhancers that are common to multiple macrophage subsets
(Figure 7E). A particularly important signal is omentum-derived
RA, which has been shown to be essential for development
and function of LPMs through its activation of RARb and induc-
tion of Gata6 (Okabe and Medzhitov, 2014). We find that all
three high-affinity retinoic acid receptor genes (Rara, Rarb,
and Rarg) are preferentially expressed in the peritoneal cavity
and that this expression requires continual maintenance by
the peritoneal cavity environment. However, only Rarb expres-
sion is preserved by RA treatment in culture, indicating that
expression of Rara and Rarg is under the control of as-yet-un-
identified factors. We speculate that the expression of RARa
and RARg is necessary for full induction of RARb expression
in response to environmental RA and that this positive feedback
loop is important for amplification of the RA signal and activa-
tion of direct RA target genes. These findings imply that at least
two environmental signals are required for initiating the RA-
dependent peritoneal macrophage phenotype, one being RA it-
self and the second being a signal or signals required for RARa
and RARg expression.
Activated retinoic acid receptors primarily function as SDTFs
that act at a common set of primed enhancers established by
PU.1 and other LDTFs that are expressed across macrophage
subsets. Importantly, direct RA target genes include Gata6,
Bhlhe40, and Nfe2, which were identified as putative interacting
partners of PU.1 through analysis of effects of natural genetic
variation. We propose that RAR-dependent induction of these
factors results in collaborative interactions with PU.1 that
drive environment-specific selection of LPM-specific enhancers
(Figure 7E).
Of note, Gata6, Bhlhe40, and Nfe2, as well as all three retinoic
acid receptors, reside in or near peritoneal macrophage-specific
SEs that are lost when LPMs are removed from the peritoneal
cavity. Our findings suggest that an analogous hierarchy oper-
ates in MG, driven in part by TGFb signaling and SMAD TFs.
Although the present studies have focused on PU.1, we expect
that additional macrophage LDTFs function in an analogous
manner to set up macrophage-specific, PU.1-independent
enhancers.Use of Natural Genetic Variation to Validate and
Discover Collaborative TFs
Here, we demonstrate the use of the natural genetic variation
provided by inbred strains of mice as a powerful means to vali-
date and discover collaborative TFs. By measuring strain-spe-
cific binding of PU.1 in macrophages derived from genetically
diverse strains of mice, we identified motifs for several different
classes of TFs in which strain-specific mutations were highly
correlated with the loss of binding of PU.1 to nonmutated PU.1
recognition motifs. Interestingly, the expression of a significant
fraction of the TFs recognizing these motifs is dependent on
environment.
Many of themotifs identified by analysis of strain-specific bind-
ingof PU.1are recognizedbyTFs that havewell-established roles
in macrophage biology. Some, such as C/EBPa and C/EBPb, are
documented to function as factors that enable collaborative bind-
ing of PU.1 in macrophages (Heinz et al., 2010), supporting the
validity of the approach. Although the biological role of Gata6 in
the development and function of LPMs is established (Okabe
andMedzhitov, 2014;Rosaset al., 2014), thepresent studies sug-
gest that a key molecular function of Gata6 is to collaborate with
PU.1, and likelyothermacrophageLDTFs, todrive theselectionof
LPM-specific enhancers. Bhlhe40 and Nfe2 represent examples
of putative collaborative partners of PU.1 that have not as yet
been linked to macrophage-specific functions. Bhlhe40, also
known as Dec1, Stra13, and Sharp2, has previously been shown
to be inducible by RA and to act as both as a repressor and
activator (Boudjelal et al., 1997; Ivanova et al., 2004), raising the
possibility that it could contribute to selection of LPM-specific en-
hancers, as well as suppress genes that become active when
LPMs are removed from the peritoneal cavity. Nfe2 is a bZip tran-
scription factor that is broadly expressed in the hematopoietic
system and has been established to play important roles in eryth-
ropoiesis and megakaryocyte development (Andrews, 1998).
The present findings provide a rationale for further investigation
of roles of Bhlhe40, Nfe2, and other TFs identified as putative
collaborative binding partners of PU.1.
The use of natural genetic variation as a strategy for identifica-
tion of TFs required for enhancer selection can in principle be
applied to any cell type in which ChIP-seq can be performed
for an index LDTF. In addition, although not a focus of the present
studies, the variation in enhancer selection and activity observed
inmacrophages derived fromdifferent inbred strains ofmicewas
associated with strain-specific differences in LPM and MG gene
expression. Such changes in gene expression are presumably
linked to both molecular phenotypes such as eQTLs and to the
marked phenotypic differences exhibited by these mice that
are influenced by tissue resident macrophage populations,
such as relative susceptibility or resistance to metabolic, cardio-
vascular, infectious, and neurodegenerative diseases (Civelek
and Lusis, 2014; Threadgill and Churchill, 2012). The principle
of collaborative binding, which serves as the basis for the motif
discovery method described here, is directly applicable to inves-
tigating mechanisms by which noncoding variants may exert
phenotypic effects in a cell-type-specific and/or context-depen-
dent manner. In concert, these approaches enable insights into
gene-by-environment interactions and the genetic architecture
of molecular and complex disease traits.Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc. 1337
Tuning Enhancer Landscapes and Gene Expression to
Context-Specific Functions
The present studies reveal that each macrophage subset
uniquely possesses a distinct set of active enhancers, including
subset-specific SEs, which are associated with strong preferen-
tial expression of nearby genes. In LPMs, for example, which
populate a very potent immunogenic environment, Gbp2b and
Alox15 are associated with SE activity, and we note that the pro-
tein products of these genes are critical regulators of immunity,
in particular inflammation and tolerance (Pilla et al., 2014; Uder-
hardt et al., 2012; Yamamoto et al., 2012). In contrast to LPMs,
MG reside in the immune-privileged environment of the brain.
As with LPMs, however, our observations suggest that MG
adopt a unique phenotype that is again strongly contributed by
distinct enhancers and SEs to accomplish tissue-specific func-
tions required for brain homeostasis. For example, SEs in MG
include genomic loci associated with the Cx3cr1 and Gpr56
genes, among others. Interestingly, both genes are highly rele-
vant to brain functions, regulating synaptic pruning and efficient
cortical patterning during brain development (Paolicelli et al.,
2011; Piao et al., 2004). Together, our studies reveal an intricate
relationship between the organization of the genome of tissue
macrophage and their surrounding environment.
Divergent Macrophage Gene Expression in a Common
Environment
Distinct macrophage populations can coexist in a similar envi-
ronment, as illustrated by the copresence of LPMs and SPMs
in the peritoneum. Although these cells are highly concordant
with respect to gene expression and organization of their
enhancer landscapes, consistent with exposure to common
tissue-derived signals, strong points of divergence can nonethe-
less discriminate the two. These observations raise the possibil-
ity that differences in origin and ontology play important roles
in determining these later-stage differences (Perdiguero et al.,
2014; Schulz et al., 2012). Thus, the impact of developmental
history on the regulation of enhancer repertoires and gene
expression of different tissue macrophages remains a funda-
mental open question to be addressed in future studies.
EXPERIMENTAL PROCEDURES
Mice
Seven-week-old C57BL/6J, NOD/ShiLtJ, and SPRET/EiJ male mice were pur-
chased from Jackson Labs and used at 8 to 9 weeks of age. All animal proce-
dures were in accordance with University of California, San Diego research
guidelines for the care and use of laboratory animals.
Microglia Isolation
Mice were anaesthetized with CO2 and quickly perfused intracardially with ice-
cold DPBS. Whole brains were removed and gently mechanically homoge-
nized on ice. Cells were fractionated by Percoll gradient centrifugation, and
microglia-enriched fractions were further purified by cell sorting according to
the scheme described in Figure S1A and Extended Experimental Procedures.
Peritoneal Macrophage Isolation
Following euthanization, peritoneal cells were collected by lavage of the peri-
toneum with ice-cold staining buffer. LPM and SPM subsets were purified
based on relative expression of MHCII and other markers described in Fig-
ure S1B and Extended Experimental Procedures.1338 Cell 159, 1327–1340, December 4, 2014 ª2014 Elsevier Inc.Thioglycollate-Elicited and Bone-Marrow-Derived Macrophages
Cultures
TGEMs were harvested by peritoneal lavage with 20 ml ice-cold PBS 4 days
after peritoneal injection of 3ml Thioglycollate broth. Both TGEMs andBMDMs
were cultured as described in Heinz et al. (2010). See also Extended Experi-
mental Procedures.
ChIP-Seq
Macrophages were fixed at room temperature with 1% paraformaldehyde/
PBS containing 1 mM sodium butyrate for 10 min and quenched with glycine.
2.03 105 to 1.03 106 cells were used for ChIP, and samples were processed
as previously described (Heinz et al., 2010), with minor modifications noted in
the Extended Experimental Procedures. Sequencing libraries were prepared
as previously described (Heinz et al., 2010).
RNA Isolation
For RNA-seq, TRIzol (Life Technologies) isolated RNA was either PolyA-
selected (MicroPoly(A) Purist kit, Ambion) or subjected to RiboZero rRNA
removal (Epicenter).
Quantitative PCR, RNA-Seq Library Preparation, and Sequencing
Libraries for RNA sequencing were generated as previously described (Heinz
et al., 2013). See Extended Experimental Procedures for details and qRT-PCR
primer sequences.
Data Analysis
Fastq files from sequencing experiments were mapped to individual genomes
for the mouse strain of origin using default parameters for STAR (Dobin et al.,
2013) (RNA-seq) and Bowtie2 (Langmead and Salzberg, 2012) (ChIP-seq).
NOD/ShiLtJ and SPRET/EiJ custom genomes were generated from invariant
positions of the mm10 sequence with alleles replaced by those reported in
VCF files from the Mouse Genomes Project (Keane et al. 2011). Mapped
data were analyzed with HOMER (Heinz et al., 2010), custom R, and Perl
scripts.
ACCESSION NUMBERS
Raw and processed data are provided in the Gene Expression Omnibus (GEO)
under accession number GSE62826.
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